+39 02 610346.1 - info@newron.com

Publications

Filter by year
  • Addition of Evenamide, a Selective Voltage Gated Sodium Channel (VGSC) Antagonist, to Atypical Antipsychotics is Efficacious in Patients Worsening on their Current Medication.
    R. Anand, R. Hartman, E. Forrest, and S. M Graham
    CINP, 16-19th June 2018, Vienna, Austria

    The Antipsychotic-like Properties of Evenamide (NW-3509) Reflect the Modulation of Glutamatergic Dysregulation
    M Bortolato, L Faravelli, R Anand
    6th Biennial Schizophrenia International Research Society (SIRS) Conference, 4-8 April 2018, Florence, Italy

    Antipsychotic Efficacy of Evenamide (NW-3509) is Due to Modulation of Glutamatergic Dysregulation
    R Anand, E Forrest, R Hartman, SM Graham, L Faravelli
    6th Biennial Schizophrenia International Research Society (SIRS) Conference, 4-8 April 2018, Florence, Italy